Free Trial
OTCMKTS:PYNKF

Perimeter Medical Imaging AI Earnings Date & Estimates

Perimeter Medical Imaging AI logo
$0.11 +0.01 (+7.31%)
As of 12:22 PM Eastern

Perimeter Medical Imaging AI is estimated to report earnings on Thursday, November 12, 2026.

What Analysts Expect from Perimeter Medical Imaging AI

Perimeter Medical Imaging AI is expected to post earnings of -$0.03 per share on revenue of $2 million.

Consensus Estimates

Consensus EPS
-$0.03
Expected Revenue
$2 million

Prepare for the Earnings Call

Perimeter Medical Imaging AI Earnings FAQ

Perimeter Medical Imaging AI (OTCMKTS:PYNKF) is estimated to report earnings on Thursday, November 12, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Perimeter Medical Imaging AI to post earnings of -$0.03 per share for the quarter.

The consensus revenue estimate for Perimeter Medical Imaging AI is $2 million for the quarter.

Perimeter Medical Imaging AI Earnings Headlines

I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
See More Perimeter Medical Imaging AI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Perimeter Medical Imaging AI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Perimeter Medical Imaging AI and other key companies, straight to your email.

About Perimeter Medical Imaging AI

Perimeter Medical Imaging AI (OTCMKTS:PYNKF) Inc. is a medical technology company focused on improving the assessment of breast tissue during cancer surgery. It develops imaging systems intended to help clinicians examine excised tissue and evaluate whether cancer may remain at the edges, or margins, of a surgical specimen.

The company’s Perimeter S-Series uses optical coherence tomography (OCT) to produce high-resolution images of tissue and has received U.S. Food and Drug Administration clearance. Its OTIS 2.0 platform is being developed to combine OCT imaging with artificial intelligence for intraoperative tissue assessment; it is investigational and should not be confused with a cleared diagnostic system.

Based in Toronto, Canada, Perimeter Medical Imaging AI focuses on the North American market, particularly breast-conserving surgery. Its technology is designed to provide surgeons with additional information during procedures, though clinical decisions remain the responsibility of healthcare professionals.

View Perimeter Medical Imaging AI Profile